Health Affairs August 24, 2023
A. Mark Fendrick

More than five million Medicare recipients struggle to pay for their prescription drugs. To make ends meet, many patients deviate from their prescribed regimen, seeking out cheaper medicines or spending less on essential items such as food, gas, or rent. In addition to the negative clinical consequences of nonadherence that disproportionately impact low-income individuals and communities of color, in certain instances failing to comply with a recommended treatment regimen can lead to increased total costs for both patients and the health care system.

In an attempt to address these concerns, last year’s Inflation Reduction Act (IRA) introduced several reforms that aimed to significantly reduce prescription drug costs. The law does so by incorporating some of the foundational elements of what’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech, Provider
Medicare prescription drug pricing variance: 5 things to know
Payer group 'deeply concerned' by Medicare weight loss drug coverage proposal
Biden administration pushes anti-obesity drug pressure to Trump
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity

Share This Article